A Review of: “Handbook of Community-Based Clinical Practice”

Much of the literature on worker-client boundaries in clinical practice is based on assumptions that the relationship between the two parties is structured and formal. These assumptions do not always apply in community-based case management practice, where the worker and client interact in a wide variety of settings and circumstances. The relative informality of case management makes the establishment of appropriate worker-client boundaries both critical and difficult. In this article key principles for recognizing and managing boundary issues are presented and discussed.

Download Full-text

Clinical Experience in Germany of Treating Community-Acquired Respiratory Infections with the New 8-Methoxyfluoroquinolone, Moxifloxacin

Journal of International Medical Research ◽

10.1177/147323000102900202 ◽

2001 ◽

Vol 29 (2) ◽

pp. 51-60 ◽

Cited By ~ 32

Author(s):

H Landen ◽

M Möller ◽

GS Tillotson ◽

R Kubin ◽

G Höffken

Keyword(s):

Adverse Drug Reaction ◽

Drug Reaction ◽

Clinical Practice ◽

Bacterial Pneumonia ◽

Respiratory Infections ◽

Symptom Relief ◽

Efficacy And Safety ◽

Community Based ◽

Acute Exacerbations ◽

Post Marketing

Moxifloxacin, a new 8-methoxyfluoroquinolone, was evaluated in a large community-based study involving 16 007 patients over a 9-month period. This study was designed as a large post-marketing observational study of the speed, efficacy and tolerability of moxifloxacin when used in clinical practice for the treatment of community-acquired bacterial pneumonia, or acute exacerbations of chronic bronchitis. Physicians and patients were specifically questioned about overall efficacy and safety as well as symptom relief. According to physicians' assessments 96.3% of patients were cured or improved after moxifloxacin treatment. Symptom relief (‘feeling better’) occurred in almost 70% of patients by day 3 and only 2.3% reported an adverse drug reaction. No individual adverse drug reaction was reported at a frequency above 1%. Among the 209 events considered as serious, only 34 were regarded as possibly or probably related to therapy. There were no moxifloxacin-related clinically relevant cases of phototoxicity, hepatotoxicity or cardiotoxicity. Overall, 92.1% of patients considered moxifloxacin to have been beneficial.

Download Full-text

An overview on medication-assisted treatment (MAT) for opioid dependence

Journal of Opioid Management ◽

10.5055/jom.2020.0560 ◽

2020 ◽

Vol 16 (2) ◽

pp. 141-149

Author(s):

Tanay Maiti, DPM, DNB ◽

Saibal Das, MD ◽

Anand Ramasamy, MPharm ◽

Alphienes Stanley Xavier, MD, DM, DNB ◽

Sapan Kumar Behera, MD, DM ◽

...

Keyword(s):

Clinical Practice ◽

Opioid Dependence ◽

Treatment Modalities ◽

Special Population ◽

Community Based ◽

Safety Issues ◽

Medication Assisted Treatment ◽

Salient Points ◽

New Treatment ◽

Broad Overview

In this article, a broad overview of medication-assisted treatment (MAT) for opioid dependence has been provided. Significant benefits of commonly used drugs (buprenorphine, methadone, and naltrexone-based regimens) along with the therapeutic aspects of other available options are highlighted. Salient points on each or individual drug therapy, comparison of pharmacological profiles of different drugs, effective clinical practice in different scenarios, relevant drug interactions, and safety issues in various populations have been emphasized. Finally, special issues, such as cost-effectiveness of different medication regimens, community-based approach, dealing with a special population, and upcoming new treatment modalities of MAT have been discussed.

Download Full-text

Clinical Practice Applications: Community Based

Health Informatics - Introduction to Nursing Informatics ◽

10.1007/0-387-32189-6_8 ◽

2006 ◽

pp. 118-128

Keyword(s):

Clinical Practice ◽

Community Based

Download Full-text